Vice President of Discovery and Technology Development at Kesmalea Therapeutics
📍 East Dunbartonshire, Scotland, United Kingdom
Justin Bower is the Vice President of Discovery and Technology Development at Kesmalea Therapeutics, a drug discovery leader with extensive experience at Cancer Research UK and AstraZeneca. He specializes in medicinal chemistry and leading teams from target identification to clinical candidate nomination. Justin earned his PhD from Loughborough University.
He displays a strong passion for science through his encouragement of colleagues and young people in the field. His professional ethos is rooted in a collaborative and open approach to scientific discovery, and he frequently celebrates the achievements of others in his network.
Unique fact: Early in his career, he focused on developing small molecule inhibitors targeting the bacterial ribosome to create novel antibiotics.
Read the full overview →
Experience
22 Years
Current Role
Vice President of Discovery and Technology Development
Job Level
Senior
Location
East Dunbartonshire, Scotland, United Kingdom
Personality Overview
How Justin shows up
Systematic
Price-Sensitive
Cautious & Analytical
They prefer to fully evaluate every situation. They generally do not appreciate an overfriendly approach and prefer to stay to-the-point. While they don't hesitate to ask questions, they are generally risk-averse and tend to be late adopters.
Priorities
Topics Justin cares about
Drug Discovery
He has a proven track record of leading drug discovery projects from the initial target identification phase all the way through to clinical candidate selection across multiple organizations.
Oncology Research
He has a deep background in cancer research, having held several senior leadership roles at Cancer Research UK's Beatson Institute before joining Kesmalea, which also has an oncology pipeline.
+5 more topicsLogin to view topics
Career
Work history
11-2022
Vice President of Discovery and Technology Development
Kesmalea Therapeutics
5-2022 - 11-2022
Vice President Chemistry and DMPK
Cancer Research UK
6-2021 - 5-2022
Head of Drug Discovery, Beatson Drug Discovery Unit, Beatson Institute for Cancer Research
Cancer Research UK Beatson Institute
3-2018 - 5-2021
Joint Head of Drug Discovery, Beatson Drug Discovery Unit
Cancer Research UK Beatson Institute
10-2014 - 3-2018
Head of Chemistry & Structural Biology
Cancer Research UK Beatson Institute
In the press
Media appearances
No media yetWe could not find public media appearances for this person.
Calculativeness (C) reflects the degree to which a person is likely to be cautious, systematic and analytical. Those scoring high tend to emphasise quality and accuracy.
More profiles
Discover additional public profiles from our index.